Safety Alerts & Recalls

Search all Safety Alerts & Recalls

Latest Alerts

Medtech Products, Inc. Recalls Several Lots of Pedia Care Infants Gas Relief Drops (Simethicone)
Medtech Products, Inc. has recalled several lots of Pedia Care Infants Gas Relief Drops (Simethicone). The following lot numbers have been recalled because the product may be contaminated with bacteria: 520-1829; 520-2047; 520-2488; 520-2513; 520-2515; 520-2660; 521-1849; 521-2048; 521-2512; 521-2517 Pedia Care Infants Gas Relief Drops contains the active ingredient Simethicone and is commonly used in the treatment of gas relief. Simethicone is also sold under other brand names. This recall alert only applies to the select lot of Pedia Care Infants Gas Relief Drops (Simethicone). No other Simethicone products were involved in this recall. To view the FDA notice about this recall, please visit: http://www.fda.gov/Safety/Recalls/EnforcementReports/ucm299000.htm
Learn More

Schering-Plough Products Recalls Single Lot of Temodar (temozolomide capsules), 5 mg
Schering-Plough Products has recalled a single lot of Temodar (temozolomide capsules), 5 mg. Lot number 0HLO008 has been recalled because samples from this lot did not pass the manufacturer's routine tests for impurities and by-products from chemical breakdown over time. Temodar contains the active ingredient temozolomide capsules and is commonly used in the treatment of specific types of brain tumor. This recall alert only applies to the single lot of Temodar (temozolomide capsules), 5 mg. No other temozolomide capsules products were involved in this recall. To view the FDA notice about this recall, please visit: http://www.fda.gov/Safety/Recalls/EnforcementReports/ucm299000.htm
Learn More

Date Published Title Drug Source
2012-05-01 Medtech Products, Inc. Recalls Several Lots of Pedia Care Infants Gas Relief Drops (Simethicone) Simethicone FDA
2012-05-01 Schering-Plough Products Recalls Single Lot of Temodar (temozolomide capsules), 5 mg Temozolomide FDA
2012-05-01 Apotex Inc. Recalls Single Lot of Cyclosporine Oral Solution, USP (modified), 100 mg/mL Cyclosporine FDA
2012-05-01 Quadrant Chemical Corporation Recalls Single Lot of DermaZinc Spray, (zinc pyritione) 0.25% Dermazinc FDA
2012-05-01 Teva Pharmaceuticals USA Recalls Single Lot of Mefloquine Tablets, 250mg Mefloquine FDA
2012-05-01 Actavis Totowa LLC Recalls Select Lots of Losartan Potassium Tablets, 50 mg Losartan FDA
2012-05-01 Teva Pharmaceuticals USA Recalls Single Lot of Claravis 40 mg Isotretinoin FDA
2012-05-01 Vintage Pharmaceuticals Recalls Single Lots of Methylprednisolone, Tablets, 4 mg Methylprednisolone FDA
2012-05-06 Novartis Consumer Health Recalls Excedrin, NoDoz, Bufferin, and Gas-X Prevention Products Manufacturer
2012-05-07 FDA Completes Safety Review of Cancer Drug Revlimid (lenalidomide) and Risk of Developing New Types of Cancers Lenalidomide FDA
2012-05-11 FDA Warns on Dangers of Unproven Treatment for Multiple Sclerosis FDA
2012-05-11 FDA Warns on Dangers of Unproven Treatment for Multiple Sclerosis Interferon Beta-1A FDA
2012-05-11 FDA Reviews Long-Term Use of Bisphosphonate Bone Drugs Ibandronate Sodium MediGuard CRT
2012-05-14 FDA Revises Recommendations for Heart Monitoring and Use of Multiple Sclerosis Drug Gilenya (Fingolimod) Fingolimod FDA
2012-05-15 Medtech Products, Inc. Recalls Several Lots of Little Fevers Children's Fever/Pain Reliever (acetaminophen) liquid, 160 mg/ 5 mL Acetaminophen FDA
2012-05-15 Teva Pharmaceuticals USA, Inc Recalls Several Lots of Tetracycline HCl Capsules USP, 250 mg and 500 mg Tetracycline FDA
2012-05-15 Actavis South Atlantic LLC Recalls Several Lots of Bupropion Hydrochloride Extended-Release Tablets (XL), 150 mg and 300 mg Bupropion FDA
2012-05-15 Forest Pharmaceuticals Inc. Recalls Several Lots of Campral (acamprosate calcium) Delayed-Release Tablets, 333 mg Acamprosate FDA
2012-05-15 Paddock Laboratories, Inc. Recalls Several Lots of Lorazepam Oral Concentrate, 2 mg/mL Lorazepam FDA
2012-05-17 FDA Issues Statement About Latest Study Regarding Azithromycin (Zithromax) and Rare Risk of Heart Related Death Azithromycin FDA